Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Deryk Jones

Sports Medicine San Carlos, CA Medical Doctor

NPI 1356390611 CMS profile 885581

301 Industrial Rd, San Carlos, CA 94070

Open in the dashboard

General payments

$915,499

542 records reported · program years 2019–2025

Research payments

$176,781

Paid to them · 25 records reported · program years 2019–2025

Ownership & investment interest

$31,248

1 holding reported · through program year 2025

Research they led as principal investigator

$605,981 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Deryk Jones of San Carlos, CA is reported in the CMS Open Payments database as having received $915,499 across 542 general payments and $176,781 in research payments paid to them. Separately, studies naming them as principal investigator received $605,981 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $31,248 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $132,809 75
2025 Research $143,258 19
2024 General $183,855 88
2024 Research $27,023 4
2023 General $77,863 63
2023 Research $6,500 2
2022 General $222,664 71
2021 General $42,237 36
2020 General $68,283 39
2019 General $187,788 170
2025 Ownership $31,248 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Deryk Jones
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Deryk Jones were reported at $132,809. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Deryk Jones Sports Medicine median Middle half National median
2019 $187,788 $1,176 $199–$4,249 $163
2020 $68,283 $708 $96–$2,890 $114
2021 $42,237 $1,213 $152–$3,994 $132
2022 $222,664 $1,230 $159–$3,998 $149
2023 $77,863 $584 $146–$2,836 $160
2024 $183,855 $628 $163–$3,168 $164
2025 $132,809 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Linvatec Corporation $327,131 93 payments
  2. Vericel Corporation $281,218 194 payments
  3. Medical Device Business Services, Inc. $166,597 81 payments
  4. Musculoskeletal Transplant Foundation Inc. $36,851 29 payments
  5. Flexion Therapeutics, Inc. $31,863 34 payments
  6. Biorez, Inc. $24,714 5 payments
  7. Amniox Medical, Inc. $17,499 7 payments
  8. Acumed LLC $11,770 10 payments
  9. DePuy Synthes Products, Inc. $7,750 4 payments
  10. Alon Medical Technology $2,082 5 payments
  11. Other $8,023 80 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $411,206 105 payments
  2. Acquisitions $207,809 9 payments
  3. Honoraria $107,275 43 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $66,402 24 payments
  5. Travel and Lodging $56,553 136 payments
  6. Grant $38,997 1 payment
  7. Food and Beverage $17,915 220 payments
  8. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $7,750 1 payment
  9. Education $1,200 1 payment
  10. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $373 1 payment
  11. Other $19 1 payment
Products named General payments · program years 2019–2025
  1. BIOBRACE 23MM $292,673 59 payments
  2. MACI Orthopedics $206,564 124 payments
  3. ORTHOCORD Sports Surgical $78,650 11 payments
  4. INTRAFIX $78,650 11 payments
  5. HEALIX $78,650 11 payments
  6. CAPITAL EQUIPMENT CART $78,650 11 payments
  7. MACI Cellular Therapy $42,776 51 payments
  8. HEALIX KNOTLESS PEEK $35,114 9 payments
  9. ORTHOCORD Sports Surgical $34,728 6 payments
  10. N/A $34,728 6 payments
  11. Other $412,850 246 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Linvatec Corporation $165,781 22 payments
  2. Episurf Medical, Inc. $11,000 3 payments

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

269

Median for Orthopedic Surgery: 203

Drug cost

$3,553

Median for Orthopedic Surgery: $1,433

Branded share of claims

4.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 114 $2,430
Methocarbamol Generic 36 $422
Pregabalin Generic 28 $246
Meloxicam Generic 62 $199
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 12 $151
Gabapentin Generic 17 $106

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$23,005

Medicare's payments for the services billed

Medicare patients

60

Average age 66

Services billed

148

36 women, 24 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 23%
Depression 20%
Chronic kidney disease 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

567 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record